Latest filing published 10 Jun 2025 for Context Therapeutics Inc., €61k.
Filing timeline
BuySaleInsider track record
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Martin A. Lehr: trading record in brief
All filings by Martin A. Lehr on record concern Context Therapeutics Inc., in the capacity of chief executive. Over a trading history stretching from 22 October 2021 to 9 June 2025, the count stands at 18 filings.
Every open-market trade on record is a purchase: 12 purchases worth €250k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2025 to date brings 1 purchase and no sales.
Half of the purchases are above €9,259 and half below. Clusters matter here: 4 out of 11 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 10 June 2025, the filings show an open-market purchase worth €61k in Context Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Martin A. Lehr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ US$0.700811.6% of flowCommon StockSEC:0001842952-25-000064:0Canonical exit: 7 Sept 2025 (T+90)
- 5,823 shares@ US$0.84150.5% of flowCommon StockSEC:0001842952-23-000030:0Canonical exit: 22 May 2023 (T+90)
- 5,606 shares@ US$0.87420.5% of flowCommon StockSEC:0001842952-23-000020:0Canonical exit: 14 May 2023 (T+90)
- 5,040 shares@ US$0.97230.5% of flowCommon StockSEC:0001842952-23-000017:0Canonical exit: 7 May 2023 (T+90)
- 7,027 shares@ US$0.69740.5% of flowCommon StockSEC:0001842952-23-000012:0Canonical exit: 30 Apr 2023 (T+90)
- 6,839 shares@ US$0.71660.5% of flowCommon StockSEC:0001842952-23-000008:0Canonical exit: 23 Apr 2023 (T+90)
- 6,783 shares@ US$0.73640.5% of flowCommon StockSEC:0001842952-23-000006:0Canonical exit: 17 Apr 2023 (T+90)
- 20,000 shares@ US$0.73981.6% of flowCommon StockSEC:0001842952-22-000112:0Canonical exit: 16 Mar 2023 (T+90)
- 13,000 shares@ US$1.85112.7% of flowCommon StockSEC:0001842952-22-000081:0Canonical exit: 17 Nov 2022 (T+90)
- 13,000 shares@ US$3.21927.0% of flowCommon StockSEC:0001842952-21-000029:0Canonical exit: 16 Mar 2022 (T+90)
- 52,680 shares@ US$7.1461.0% of flowCommon StockSEC:0001842952-21-000027:0
- 10,000 shares@ US$5.008.1% of flowCommon StockSEC:0001179110-21-009609:0Canonical exit: 20 Jan 2022 (T+90)
12 of 12 declarations